Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-24-000066
Filing Date
2024-08-19
Accepted
2024-08-19 16:26:41
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3938
  Complete submission text file 0001235802-24-000066.txt   5546
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Issuer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11621 RESEARCH CIRCLE ALACHUA FL 32615
Business Address
Brandt Kevin D (Reporting) CIK: 0001692661 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34951 | Film No.: 241220922